Skip to main content
. 2018 Jul 30;119(4):517–522. doi: 10.1038/s41416-018-0215-6

Table 1.

Patient and tumour characteristics according to country (2001–2010)

Characteristics Belgium (n = 3627)a Denmark (n = 2444) Netherlands (n = 6465) Norway (n = 2925) Sweden (n = 4173)
Rectal cancer
Sex
 Male 1766 (48.7) 1206 (49.4) 3022 (46.7) 1427 (48.8) 2175 (52.1)
 Female 1861 (51.3) 1238 (50.6) 3443 (53.3) 1498 (51.2) 1998 (47.9)
Age (years)
 80–84 2213 (61.0) 1368 (56.0) 3843 (59.4) 1645 (56.2) 2421 (58.0)
 85–89 1073 (29.6) 788 (32.2) 1982 (30.7) 919 (31.4) 1312 (31.4)
 90–94 278 (7.7) 249 (10.2) 559 (8.6) 302 (10.3) 372 (8.9)
 95–99 58 (1.6) 38 (1.6) 77 (1.2) 51 (1.7) 64 (1.5)
 100+ 5 (0.1) 1 (0.04) 4 (0.1) 8 (0.3) 4 (0.1)
Stage
 I 631 (17.4) 375 (15.3) 1474 (22.8) 951 (32.5) 732 (17.5)
 II 858 (23.7) 550 (22.5) 1618 (25.0) 499 (17.1) 879 (21.1)
 III 918 (25.3) 421 (17.2) 1331 (20.6) 539 (18.4) 887 (21.3)
 IV 457 (12.6) 640 (26.2) 996 (15.4) 497 (17.0) 698 (16.7)
 Unknown 763 (21.0) 458 (18.7) 1046 (16.2) 439 (15.0) 977 (23.4)
Grade
 I 562 (15.5) b 310 (4.8) b 128 (3.1)
 II 1780 (49.1) b 3026 (46.8) b 1005 (24.1)
 III 434 (12.0) b 647 (10.0) b 159 (3.8)
 Unknown 851 (23.5) b 2482 (38.4) b 2881 (69.0)

Data are presented as n(%)

aOnly data of the period 2004–2010 were available

bNot registered in data set